Insider Transactions in Q4 2024 at Angion Biomedica Corp. (ANGN)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2024
|
Peter De Muth Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
381
+50.0%
|
$1,524
$4.41 P/Share
|
|
Nov 26
2024
|
Jay Venkatesan Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
50,000
+21.78%
|
$0
$0.01 P/Share
|